Tsukuba, Japan

Seiji Yoshimura

This inventor holds 1 USPTO granted patent. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seiji Yoshimura. Retrieved from https://idiyas.com/inventor/seiji-yoshimura-vrh55rjb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Seiji Yoshimura: Innovator in Amino Acid Derivatives

Introduction

Seiji Yoshimura is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of amino acid derivatives. His work has implications for various medical applications, especially in the inhibition of phospholipase A.sub.2.

Latest Patents

Yoshimura holds a patent for "Amino acid derivatives and their use as phospholipase A.sub.2 inhibitor." This patent highlights his innovative approach to creating compounds that can potentially lead to advancements in therapeutic treatments.

Career Highlights

Seiji Yoshimura is associated with Fujisawa Pharmaceutical Company, Ltd., where he has been instrumental in research and development. His expertise in biochemistry has allowed him to contribute to the company's mission of improving health through innovative pharmaceutical solutions.

Collaborations

Yoshimura has worked alongside talented colleagues such as Takanao Otsuka and Naoki Fukami. Their collaborative efforts have fostered a productive research environment, leading to advancements in their respective fields.

Conclusion

Seiji Yoshimura's contributions to the field of amino acid derivatives exemplify the impact of innovative research in pharmaceuticals. His work continues to inspire advancements in medical science and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…